Five prime therapeutics, inc. (FPRX)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Operating activities
Net loss

-

-

-

-

249,647

-37,424

-28,872

-27,595

-

Net loss

-137,202

-140,447

-150,222

-65,697

-

-

-

-

19,710

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

5,300

5,000

2,500

1,742

1,678

1,552

1,694

1,643

1,631

Impairment of fixed assets

1,959

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-38

-95

-9

-3

-41

-

5

-2

Stock-based compensation expense

22,815

29,468

34,173

32,885

11,467

3,418

2,146

-

-

Amortization of discounts and premiums on marketable securities

2,163

1,750

-1,621

-4,187

-2,025

-1,491

-432

-

-

Non-cash operating lease expense

2,351

-

-

-

-

-

-

-

-

Revaluation of preferred stock warrant liability

-

-

-

-

-

-

500

119

-60

Excess tax benefits from employee equity incentive plans

-

-

-

-3,123

-3,122

-

-

-

-

Deferred income taxes

-

-

-

15,071

-15,071

-

-

-

-

Stock-based compensation expense

-

-

-

-

-

-

-

1,721

2,927

Amortization of premium on marketable securities

-

-

-

-

-

-

-

538

892

Changes in operating assets and liabilities:
Receivables from collaborative partners

-999

-8,037

9,174

-95

3,644

114

-101

-449

846

Income tax receivable

-

-

-4,670

4,670

-

-

-

-

-

Prepaid, other current assets and other long-term assets

-6,800

10,120

-4,235

2,999

4,782

579

981

-372

313

Restricted cash

-

-

-

1,543

-

-

-

-

-

Accounts payable

-72

-265

1,903

-1,560

798

701

-209

196

-729

Accrued personnel-related expenses

-578

227

-801

1,079

2,260

1,661

707

-19

656

Deferred revenue

-5,484

-9,670

-9,070

-16,771

-

-

-

-

-

Payable to collaborative partner

-

-

-

-

-

-

-

-3,000

3,000

Deferred revenue

-

-

-

-

-11,789

45,530

280

7,379

-5,188

Deferred rent

-

802

3,699

-768

-513

-549

247

457

696

Income tax payable

-

-

-

-52,843

49,720

-

-

-

-

Other accrued liabilities, and other long-term liabilities

-5,699

-3,854

4,174

8,909

4,177

-463

-375

-

-

Operating lease liabilities

-2,905

-

-

-

-

-

-

-

-

Other accrued liabilities and other long-term liabilities

-

-

-

-

-

-

-

-414

789

Net cash used in operating activities

-

-

-

-

289,098

15,265

-25,330

-18,397

-

Net cash used in operating activities

-113,866

-122,514

-112,184

-79,751

-

-

-

-

23,287

Investing activities
Purchases of marketable securities

193,063

377,365

330,363

516,752

458,058

158,674

79,776

45,419

71,773

Maturities of marketable securities

321,015

386,200

509,500

466,000

222,250

90,955

38,403

-

-

Proceeds from disposal of property and equipment

-

-

12

-

-

-

-

-

-

Maturities of marketable securities

-

-

-

-

-

-

-

64,636

45,738

Purchases of property and equipment

1,776

11,331

4,941

2,961

2,426

1,643

807

737

970

Change in restricted cash

-

-

-

-

-

-

-

-38

-

Net cash (used in) provided by investing activities

-

-

-

-

-238,234

-69,362

-42,180

18,518

-

Net cash provided by investing activities

126,176

-2,496

174,208

-53,713

-

-

-

-

-27,005

Financing activities
Proceeds from public offering of common stock, net of issuance costs

-

107,612

-

-

78,693

58,728

63,849

-

-

Deferred offering costs

-

-

-

-

-

16

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

39

Proceeds from issuances of convertible preferred stock, net of issuance costs)

-

-

-

-

-

-

-

6,819

-

Proceeds from issuance of common stock under equity incentive plans

1,136

3,963

4,022

8,323

5,147

2,459

440

105

-

Repurchase of shares to satisfy tax withholding obligations

1,599

2,402

13,909

14,054

-

-

-

-

-

Excess tax benefits from employee equity incentive plans

-

-

-

3,123

-

-

-

-

-

Net cash used in financing activities

-463

109,173

-9,887

-8,854

-

-

-

-

26

Net increase (decrease) in cash and cash equivalents and restricted cash

11,847

-15,837

52,137

-142,318

-

-

-

-

-

Supplemental disclosure
Payments under capital lease obligation

-

-

-

-

-

-

9

15

13

Net cash provided by (used in) financing activities

-

-

-

-

83,840

61,203

64,280

6,909

-

Income taxes paid

-

-

1,704

11,433

-

-

-

-

-

Property and equipment purchases included in accrued liabilities

29

716

9,033

1,232

-

-

-

-

-

Tenant improvement by the landlord

-

-

14,324

-

-

-

-

-

-

Supplemental cash flow information
Net increase (decrease) in cash and cash equivalents

-

-

-

-

134,704

7,106

-3,230

7,030

-3,692

Accrued and deferred offering costs

-

-

-

-

-

144

-

-

-